CLEAR Consortium: Discovering the Developmental Mechanisms of Trachea-Esophageal Birth Defects

CLEAR联盟:发现气管-食管先天缺陷的发育机制

基本信息

  • 批准号:
    10458157
  • 负责人:
  • 金额:
    $ 163.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-08-15 至 2027-05-31
  • 项目状态:
    未结题

项目摘要

OVERALL | PROJECT SUMMARY The goal of the CLEAR Consortium is to elucidate the developmental and genetic mechanisms of trachea- esophageal birth defects (TEDs) to better understand their etiology, enhance diagnosis, improve treatment, and inform strategies to generate tissue in vitro that might ultimately be used for repair. The trachea and esophagus arise from the separation of a common foregut tube during early fetal development. Defects in trachea- esophageal development cause a spectrum of life-threatening TEDs, which occur in ~1:3500 births and prevent proper breathing and feeding in newborn infants. Gene mutations are known to cause TEDs but have only been identified in ~15% of cases and how these cause congenital malformations is poorly defined. To address this unmet need we have assembled an experienced and highly collaborative multi-disciplinary team of clinicians, surgeons, geneticists, computational scientists, and developmental and stem cell biologists that use an innovative combination of patient genome sequencing, neonatal MRI, animal models, quantitative cell biology, single cell genomics, CRISPR gene editing and human PSCs-derived organoids to study TEDs. This Multi-PI project centered at Cincinnati Children’s Hospital (CCHMC) and Columbia University Medical Center (CUMC) is led by Wendy Chung MD PhD (CUMC), Paul Kingma MD PhD (CCHMC), Yufeng Shen PhD (CUMC), James Wells PhD (CCHMC) and Aaron Zorn PhD (contact PI; CCHMC). Our program has 3 projects linked together by an Integrated Genomics Core. Project-1: Comprehensive phenotypic and genetic assessment of TED patients. Project-2: Defining the developmental mechanisms of TEDs in animal models. Project-3: Modeling EA in human PSC-derived embryonic tissues.
整体|项目摘要 CLEAR联盟的目标是阐明气管的发育和遗传机制, 食管出生缺陷(TEDs),以更好地了解其病因,提高诊断,改善治疗, 为在体外生成最终可能用于修复的组织提供了信息策略。气管和食管 在早期胎儿发育过程中,共同的前肠管分离而产生。气管缺陷- 食管发育引起一系列危及生命TED,发生率约为1:3500, 新生儿的正确呼吸和喂养。已知基因突变会导致TED,但目前为止 在约15%的病例中发现,这些疾病如何导致先天性畸形尚不清楚。为了解决这个 未满足的需求我们已经组建了一支经验丰富、高度协作的多学科临床医生团队, 外科医生,遗传学家,计算科学家,发育和干细胞生物学家, 患者基因组测序、新生儿MRI、动物模型、定量细胞生物学 单细胞基因组学、CRISPR基因编辑和人类PSC衍生的类器官来研究TED。这多PI 一个以辛辛那提儿童医院(CCHMC)和哥伦比亚大学医学中心(CAMC)为中心的项目, 由Wendy Chung MD PhD(CUMC)、Paul Kingma MD PhD(CCHMC)、Yufeng Shen PhD(CUMC)、James领导 威尔斯博士(CCHMC)和Aaron Zorn博士(联系PI; CCHMC)。我们的项目有三个项目, 整合基因组学核心 项目-1:TED患者的综合表型和遗传评估。 项目-2:在动物模型中定义TED的发育机制。 项目3:在人PSC衍生的胚胎组织中建模EA。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Wendy K Chung其他文献

Recent advances in understanding neurodevelopmental outcomes in congenital heart disease
先天性心脏病神经发育结局理解方面的最新进展

Wendy K Chung的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Wendy K Chung', 18)}}的其他基金

Fair Phenotype Annotation and Genomic Reinterpretation
公平表型注释和基因组重新解释
  • 批准号:
    10675315
  • 财政年份:
    2023
  • 资助金额:
    $ 163.99万
  • 项目类别:
Prospective Genetic Risk Evaluation and Assessment (PROGRESS) in Autism
自闭症的前瞻性遗传风险评估(PROGRESS)
  • 批准号:
    10531728
  • 财政年份:
    2022
  • 资助金额:
    $ 163.99万
  • 项目类别:
Prospective Genetic Risk Evaluation and Assessment (PROGRESS) in Autism
自闭症的前瞻性遗传风险评估(PROGRESS)
  • 批准号:
    10698037
  • 财政年份:
    2022
  • 资助金额:
    $ 163.99万
  • 项目类别:
Project 1: Identifying and optimizing monogenetic risk prediction for autism in newborns
项目 1:识别和优化新生儿自闭症单基因风险预测
  • 批准号:
    10698081
  • 财政年份:
    2022
  • 资助金额:
    $ 163.99万
  • 项目类别:
Core A: Administrative Core
核心A:行政核心
  • 批准号:
    10698072
  • 财政年份:
    2022
  • 资助金额:
    $ 163.99万
  • 项目类别:
Identifying and applying genetic variation relevant to clinical outcomes for individuals with congenital heart disease
识别和应用与先天性心脏病患者临床结果相关的遗传变异
  • 批准号:
    10028016
  • 财政年份:
    2020
  • 资助金额:
    $ 163.99万
  • 项目类别:
Role of the Kinesin KIF1A in Neurological Disease
驱动蛋白 KIF1A 在神经系统疾病中的作用
  • 批准号:
    10328907
  • 财政年份:
    2020
  • 资助金额:
    $ 163.99万
  • 项目类别:
Molecular Biology/Molecular Genetics (Core C)
分子生物学/分子遗传学(核心 C)
  • 批准号:
    9901512
  • 财政年份:
    2020
  • 资助金额:
    $ 163.99万
  • 项目类别:
Role of the Kinesin KIF1A in Neurological Disease
驱动蛋白 KIF1A 在神经系统疾病中的作用
  • 批准号:
    10543786
  • 财政年份:
    2020
  • 资助金额:
    $ 163.99万
  • 项目类别:
Identifying and applying genetic variation relevant to clinical outcomes for individuals with congenital heart disease
识别和应用与先天性心脏病患者临床结果相关的遗传变异
  • 批准号:
    10226278
  • 财政年份:
    2020
  • 资助金额:
    $ 163.99万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 163.99万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 163.99万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 163.99万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 163.99万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 163.99万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 163.99万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 163.99万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 163.99万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 163.99万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 163.99万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了